Clinical Trial

VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors

Name: VGN-Ex05e in Patients With Autism Spectrum Disorder Associated With Severe Self-Injurious and Aggressive Behaviors — clinical trial record (NCT07433517)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the safety and tolerability of intracerebral injection of VGN-Ex05e in the nucleus accumbens of patients with autism spectrum disorder.

Trial Details

NCT Number	NCT07433517
Lead Sponsor	Shanghai Jiao Tong University School of Medicine Collaborators: Shanghai Vitalgen BioPharma Co., Ltd.
Conditions	Autism Spectrum Disorder
Enrollment	6 participants
Start Date	2026-04
Primary Completion	2027-10 (estimated)
Study Completion	2027-10 (estimated)
Updated on ClinicalTrials.gov	2026-02-25